PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing
- PMID: 12881194
- DOI: 10.1080/1061186031000138623
PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing
Abstract
Mixed micelles were prepared from poly(ethyleneglycol)-distearyl phosphoethanolamine (PEG2000-PE) and egg phosphatidylcholine. The micelles were covalently modified with the nucleosome-specific monoclonal antibody 2C5 known to recognize and bind a variety of tumor cells via their surface-bound nucleosomes. Covalent attachment of 2C5 antibody was performed via a micelle-incorporated PEG-PE with the distal terminus of the PEG block activated with p-nitrophenylcarbonyl group (pNP-PEG-PE). Micelle surface-attached 2C5 antibody maintained its specific activity. 2C5-targeted immunomicelles were able to carry more than 3 wt% of taxol. Taxol-loaded immunomicelles specifically recognized tumor cell lines of several types. The cytotoxicity of 2C5-targeted taxol-loaded immunomicelles in a cell culture model was much higher when compared with free taxol or taxol in non-targeted micelles.
Similar articles
-
Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.Eur J Pharm Biopharm. 2008 Sep;70(1):51-7. doi: 10.1016/j.ejpb.2008.04.016. Epub 2008 Apr 29. Eur J Pharm Biopharm. 2008. PMID: 18583114 Free PMC article.
-
pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.Biomaterials. 2013 Jan;34(4):1213-22. doi: 10.1016/j.biomaterials.2012.08.072. Epub 2012 Oct 24. Biomaterials. 2013. PMID: 23102622 Free PMC article.
-
Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles.J Drug Target. 2008 Jul;16(6):486-93. doi: 10.1080/10611860802102175. J Drug Target. 2008. PMID: 18604661
-
Antinuclear antibodies with nucleosome-restricted specificity for targeted delivery of chemotherapeutic agents.Ther Deliv. 2010 Aug;1(2):257-72. doi: 10.4155/tde.10.30. Ther Deliv. 2010. PMID: 22816132 Review.
-
Targeted polymeric micelles for delivery of poorly soluble drugs.Cell Mol Life Sci. 2004 Oct;61(19-20):2549-59. doi: 10.1007/s00018-004-4153-5. Cell Mol Life Sci. 2004. PMID: 15526161 Free PMC article. Review.
Cited by
-
Immunoconjugates and long circulating systems: origins, current state of the art and future directions.Adv Drug Deliv Rev. 2013 Jan;65(1):24-35. doi: 10.1016/j.addr.2012.08.009. Epub 2012 Sep 3. Adv Drug Deliv Rev. 2013. PMID: 22964425 Free PMC article. Review.
-
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070. Pharmacol Rev. 2016. PMID: 27363439 Free PMC article. Review.
-
Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids.J Drug Target. 2005 Jan;13(1):73-80. doi: 10.1080/10611860400011935. J Drug Target. 2005. PMID: 15848957 Free PMC article.
-
Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer.J Inorg Biochem. 2019 Oct;199:110780. doi: 10.1016/j.jinorgbio.2019.110780. Epub 2019 Jul 18. J Inorg Biochem. 2019. PMID: 31434020 Free PMC article. Review.
-
Paclitaxel Nano-Delivery Systems: A Comprehensive Review.J Nanomed Nanotechnol. 2013 Feb 18;4(2):1000164. doi: 10.4172/2157-7439.1000164. J Nanomed Nanotechnol. 2013. PMID: 24163786 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous